Continuous patient monitoring

RespArray™ patient monitor

0:00 / 0:00

Continuous patient monitoring

RespArray™ patient monitor

The RespArray™ patient monitor can help continuously monitor SpO₂, etCO₂, ECG, and temperature, measure NiBP, and connect wirelessly to EMR via HL7.

Description

Safety made simple

We have an unwavering commitment to keep our patients safe. But staffing shortages can make it challenging to check on your patients as often as you’d like.

What if you could monitor patients from anywhere in the hospital? Now you can, with the the RespArray™ patient monitor.

It's designed to continuously monitor patients in areas of care where spot checking might not be enough or where additional parameters are needed — for example, in medical-surgical units or for capnography use in procedural sedation. The RespArray™ patient monitor can help you detect respiratory compromise early and intervene sooner.

Features

Simplification: smart, connected, and intuitive

The RespArray™ patient monitor features simple connectivity and seamlessly integrates into workflow. You’ll have more time to focus on your patients.

  • Includes an HL7 interface, is WiFi-enabled, connects to your EMR and Vital Sync™ remote patient monitoring system — giving you more visibility, wherever you are
  • Features a large, intuitive touchscreen you can see from multiple angles and from a distance

 

96%

On average, medical-surgical registered nurses spend 96% of their shift away from the patient’s bedside.1

 

This is an image of the RespArray™ patient monitor being used by a medical professional.

Patient safety: manage risk — and alarms

Experience world-class Nellcor™ pulse oximetry and Microstream™ capnography technologies, designed to detect respiratory compromise early — and help reduce alarm fatigue.

  • See trends with near real-time monitoring so you can get to your patients sooner.
  • Patient monitor includes SpO2 (Nellcor™ pulse oximetry) and etCO2 (Microstream™ capnography) proprietary algorithms, plus ECG, NiBP, and continuous and spot check (optional) temperature monitoring.

 

53%

The Smart Alarm for Respiratory Analysis™ (SARA) in Microstream™ technology reduces unnecessary nuisance alarms by 53%.2

 

View an image of a male patient lying in a hospital bed being monitored by a patient monitoring system.

Support: continuous monitoring, continuous support

Your dedicated white-glove service team is with you every step of the way. Customizable plans and service options are tailored to fit your needs.

  • Get optimal value with next-level support, education, and training that more effectively reduces adverse events and enables your team to deliver exceptional patient care.
  • Your Medtronic team includes tenured nursing professionals, respiratory therapists, informatics experts, and engineers. They have the background, experience, and knowledge to understand your challenges and optimally implement the monitor within your workflow.

 

$535K

Average amount that continuous monitoring of high-risk patients may help a median-sized hospital save annually†,3

 

This is an image of three healthcare professionals in a meeting.

Frequently asked questions

Ordering information

 

Item number Description Units per box
RESPARRAYAHA01 RespArray™ patient monitor — AHA (American Heart Association) version 1
RESPARRAYKITAHA RespArray™ patient monitor bundle 1

 

 

 

Resources

In-service videos

Select a module below to watch an interactive video.

This is the initial still image for module 1 of the RespArray™ monitor hybrid eLearning video series.

Module 1: Why the RespArray™ patient monitor?

Watch video

This is the initial still image for module 2 of the RespArray™ monitor hybrid eLearning video series.

Module 2: Overview of the RespArray™ patient monitor

Watch video

This is the initial still image for module 3 of the RespArray™ monitor hybrid eLearning video series.

Module 3: RespArray™ patient monitor interface

Watch video

This is the initial still image for module 1 of the RespArray™ monitor hybrid eLearning video series.

Module 4: RespArray™ patient monitor parameters

Watch video

This is the initial still image for module 5 of the RespArray™ monitor hybrid eLearning video series.

Module 5: RespArray™ patient monitor workflow overview

Watch video

This is the initial still image for module 6 of the RespArray™ monitor hybrid eLearning video series.

Module 6: Alarms and troubleshooting

Watch video

The measurements provided through the RespArray™ patient monitor, including Nellcor™, Microstream™, and other vital signs, should not be used as the sole basis for diagnosis or therapy and are intended only as adjuncts to patient assessment.

This assumes a 20% respiratory depression reduction and an annual general care floor volume of 2,447 patients receiving opioids per median-sized hospital. 90% of surgical patients and 45% of medical patients on U.S. general care floors receive opioids. Continuous pulse oximetry and capnography device pricing assumptions used list pricing for the following: a Capnostream 35 portable respiratory monitor prorated over seven years; a Microstream capnography filter line, and a disposable Nellcor pulse oximetry sensor, resulting in $52.73 in device costs per continuously monitored patient stay on a medical surgical floor. For intermittent pulse oximetry monitoring, device pricing consisted of a multiparameter monitor prorated over seven years and a reusable pulse oximetry sensor, resulting in $0.68 in device costs per patient stay. Additional information on pricing and assumptions are available in the study publication.


  1. Hendrich A, Chow M, Skierczynski B, Lu Z. A 36-hospital time and motion study: how do medical-surgical nurses spend their time? Perm J. 2008;12(3):25–34.
  2. Hockman S, Glembot T, Niebel K. Comparison of capnography derived respiratory rate alarm frequency using the SARA algorithm versus an established non-adaptive respiratory rate alarm management algorithm in bariatric surgical patients. Respir Care. 2009;54(11):1582.
  3. Khanna AK, Junquist CR, Buhre W, Soto R, Di Piazza F, Saager L, et al. Modeling the cost savings of continuous pulse oximetry and capnography monitoring of United States general care floor patients receiving opioids based on the PRODIGY trial. Adv Ther. 2021;38(7):3745–3759.